VALENCIA, Calif., Feb. 21, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation
(NASDAQ:MNKD) (TASE:MNKD) today confirmed that it received $16.7 million on February 17, 2017, upon closing the sale of real estate owned by the Company in Valencia, California, net of closing costs.


About MannKind Corporation

MannKind Corporation (NASDAQ:MNKD) (TASE:MNKD) focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes. MannKind maintains a website at http://www.mannkindcorp.com to which MannKind regularly posts copies of its press releases as well as additional information about MannKind. Interested persons can subscribe on the MannKind website to e-mail alerts that are sent automatically when MannKind issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the website. 


Company Contact:
Rose Alinaya
SVP, Finance
661-775-5300
ralinaya@mannkindcorp.com

MNKD

Exchange:
NASDAQ GM and TASE(US Dollar)

Price:0.53

Change: 0.00 (0.000%)

Volume:1,000

Data as of
02/17/2017 04:00 PM ET .
Minimum 20 minute delay.

Refresh Quote >

MannKind Corporation published this content on 21 February 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 21 February 2017 14:04:06 UTC.

Original documenthttp://investors.mannkindcorp.com/releasedetail.cfm?ReleaseID=1012684

Public permalinkhttp://www.publicnow.com/view/54AEFE59F7DF8782CCA10060DFB1ADB25D1383DB